Clinical Trial

Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2026 (before its estimated May 7, 2026 completion). Its status may not reflect the trial's current state.
Summary
A phase 1 healthy volunteer study to assess the excretion and metabolism as well as the absolute bioavailability of oral JMKX003142. The study will be conducted in two parts: Part 1 to assess the mass balance of JMKX003142 using orally administered radiolabelled JMKX003142; part 2 will assess the absolute bioavailability using JMKX003142 and radiolabelled JMKX003142 as intravenous and oral forms
Trial Details
NCT Number NCT07463053
Lead Sponsor Jemincare
Collaborators: Zhejiang Hangyu Pharmaceutical Co., Ltd.
Conditions ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Enrollment 8 participants
Start Date 2026-03-18
Primary Completion 2026-05-07 (estimated)
Study Completion 2026-06-11 (estimated)
Updated on ClinicalTrials.gov 2026-03-10